These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 13399941)

  • 1. [Clinical use of a new drug with sedative action: 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate].
    RIGOTTI S
    Minerva Med; 1956 Dec; 47(102):2178-81. PubMed ID: 13399941
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychiatric use of a new tranquilizer: 2-methyl-2-N-propyl-1,3-propanediol dicarbamate (meprobamate).
    MACCAGNANI G
    Rass Neuropsichiatr; 1957; 11(3-4):145-71. PubMed ID: 13506106
    [No Abstract]   [Full Text] [Related]  

  • 3. A clinical evaluation of miltown (2 methyl-2-N-propyl-1, 3 propanediol dicarbamate).
    WEINSTEIN GJ
    N Y State J Med; 1957 Jun; 57(12):2060. PubMed ID: 13441048
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of administration of 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate (meprobamate) in mental disorders].
    IMBERCIADORI S; MANGANARO D
    Minerva Med; 1956 Dec; 47(102):2181-4. PubMed ID: 13399942
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new therapeutic agent against anxiety states; meprobamate (2-methyl-2-N-propyl-1, 3-propandiol dicarbamate)].
    SPOTA BB
    Sem Med; 1957 Feb; 110(7):237-8. PubMed ID: 13454968
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methyl-propyl-propanediol dicarbamate (meprobamate) in dermatology].
    KAMINSKY A; KAPLAN A; SEVINSKY B
    Minerva Med; 1956 Nov; 47(88):1478-80. PubMed ID: 13387292
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of 2-methyl-2-N-propyl-1, 3-propanediol dicarbamate in psychiatry].
    FLORIS V; RAMBELLI L
    Minerva Med; 1956 Nov; 47(88):1455-7. PubMed ID: 13387286
    [No Abstract]   [Full Text] [Related]  

  • 8. [Meprobamate (2-methyl-2-n propyl-1,3 proprandiol dicarbamate) in glaucoma & preoperative care in eye surgery].
    LEYDHECKER W
    Klin Monbl Augenheilkd Augenarztl Fortbild; 1958; 132(2):224-33. PubMed ID: 13550760
    [No Abstract]   [Full Text] [Related]  

  • 9. Aplastic anemia after meprobamate (2-methyl-2-N-propyl-1,3-propanediol dicarbamate) therapy.
    MEYER LM; HEEVE WL; BERTSCHER RW
    N Engl J Med; 1957 Jun; 256(26):1232-3. PubMed ID: 13452030
    [No Abstract]   [Full Text] [Related]  

  • 10. [Personal experience with 2-methyl-2-propyl-1, 3-propanediol dicarbamate in a group of allergic patients].
    GARAT B; BERRUEZO JJ; ORCIUELI L
    Dia Med; 1957 Mar; 29(10):234; passim. PubMed ID: 13427602
    [No Abstract]   [Full Text] [Related]  

  • 11. [Early clinical experiments with 2-methyl-2-propyl-1,3-propandiol dicarbamate; new substance with sedative action].
    BALDUINI M
    Farmaco Prat; 1956 Oct; 11(10):565-70. PubMed ID: 13414830
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of 2-methyl-2-N-propyl-1,3-propanediol dicarbamate (meprobamate) on the spinal electric potential in frogs].
    RAPUZZI G; DOZIO G
    Arch Ital Sci Farmacol; 1958 Jan; 8(1):74-84. PubMed ID: 13522415
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methyl - propyl - propanediol dicarbonate (meprobamate) in dermatology].
    KAMINSKY A; KAPLAN A; SEVINSKY B
    Dia Med; 1956 Oct; 28(74):2284-6. PubMed ID: 13397363
    [No Abstract]   [Full Text] [Related]  

  • 14. [2-Methyl-2-n-propyl-1, 3-propandiol-dicarbamate (meprobamate); experimental results, clinical experiences and own studies on the determination of excretion products].
    RIEBELING C
    Arzneimittelforschung; 1957 Mar; 7(3):181-5. PubMed ID: 13425940
    [No Abstract]   [Full Text] [Related]  

  • 15. Gas chromatographic determination of meprobamate, 2-methyl-2-propyl-1,3-propanediol dicarbamate, in plasma and urine.
    Douglas JF; Kelley TF; Smith NB; Stockage JA
    Anal Chem; 1967 Jul; 39(8):956-8. PubMed ID: 6042638
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxic reaction to 2-methyl-2-n-propyl-1, 3, propanediol dicarbamate (miltown and equanil).
    HOLOUBEK JE; THOMAS OC; SEGURA J
    Ann Intern Med; 1957 May; 46(5):1002-4. PubMed ID: 13411911
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent.
    BERGER FM
    J Pharmacol Exp Ther; 1954 Dec; 112(4):413-23. PubMed ID: 13222235
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary institutional evaluation of a new drug in cerebral palsy: N-isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate (soma).
    PHELPS WM
    Arch Pediatr (N Y); 1959 Jun; 76(6):243-50. PubMed ID: 13662106
    [No Abstract]   [Full Text] [Related]  

  • 19. Central depressant and anticonvulsant activity of compounds isomeric with 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate (miltown).
    BERGER FM; HENDLEY CD; LUDWIG BJ; LYNES TE
    J Pharmacol Exp Ther; 1956 Mar; 116(3):337-42. PubMed ID: 13307395
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.